- Home
- PLCE vs EDSA Comparison
PLCE vs EDSA Comparison
Compare PLCE & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLCE | EDSA |
|---|---|---|
| Founded | 1969 | 2015 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.5M | 56.1M |
| IPO Year | 1997 | 2018 |
Fundamental Metrics
Financial Performance| Metric | PLCE | EDSA |
|---|---|---|
| Price | $2.72 | $5.68 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.50 | ★ $5.00 |
| AVG Volume (30 Days) | ★ 307.8K | 95.4K |
| Earning Date | 04-10-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.48 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.41 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.53 | $0.72 |
| 52 Week High | $9.56 | $20.32 |
Technical Indicators
Market Signals| Indicator | PLCE | EDSA |
|---|---|---|
| Relative Strength Index (RSI) | 37.75 | 35.31 |
| Support Level | N/A | $4.87 |
| Resistance Level | $3.81 | $6.58 |
| Average True Range (ATR) | 0.18 | 0.53 |
| MACD | -0.02 | -0.10 |
| Stochastic Oscillator | 25.93 | 1.63 |
Price Performance
Historical ComparisonAbout PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.